Surveys of Interest to MFM's
The Society supports its members and other clinicians in the field by promoting various research activities. SMFM does not conduct or endorse the surveys below.
However, if you meet the requirements provided by the researchers, you are invited to participate. If you do not meet the specifications, you are welcome to "browse" the survey, but please refrain from completing it. SMFM charges an administrative fee to post and distribute these surveys.
If you are interested in submitting a member or non-member survey, please review our survey process guidelines for more information.
Understanding the Implementation of Outpatient Cervical Ripening With Cervical Ripening Balloons - A National Survey Study Posted 2/5/2026
This national survey aims to describe current practices for outpatient cervical ripening using cervical ripening balloons across U.S. clinical sites. The survey assesses institutional workflows, eligibility criteria, patient counseling, and operational considerations related to the implementation of these programs. Eligible respondents include Maternal-Fetal Medicine physicians, OB/GYN physicians, residents/fellows, advanced practice providers, nurses, and other clinicians or administrators who are involved in labor and delivery care and have familiarity with cervical ripening balloon use and related processes at their clinical site. The anonymous survey collects site-level information, takes approximately 15–30 minutes to complete, and results will be reported in aggregate to inform best practices and support program development.
Clinician Attitudes Surrounding a combined screening test for prenatal aneuploidies and recessive conditions Posted 1/21/2026
This is a quantitative research study focused on clinician attitudes toward a single-gene prenatal cfDNA screen.
Research Team: This research is being conducted by Baylor University, Rutgers University and Myriad Genetics, Inc. and has been determined exempt from IRB oversight by Advarra Institutional Review Boards (IRB#00000971).
Survey Details: 24 questions, approximately 15–20 minutes to complete.
Brief Explanation: While existing literature demonstrates the accuracy and potential value of combined single-gene cfDNA screens, little is known about clinician attitudes. This study aims to identify factors influencing adoption, perceived barriers, and opportunities to address disparities in care, inform guidelines, and shape future iterations of these tests.
Eligibility: An English-speaking healthcare professional (Ob/Gyn, genetic counselor, MFM, APP) who is practicing in a reproductive space taking care of pregnant patients in the United States.